Lymphangiogenesis: A new strategy for heart disease treatment (Review)

Liding Bai1, Yanyan Wang1, Siqi Du1

  • 1Ministry of Education Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Tianjin 301617, P.R. China.

Insights

Lymphangiogenesis, the formation of new lymphatic vessels, is crucial for heart health. This review explores how improving lymphatic function may treat heart disease, highlighting Traditional Chinese Medicine

Area of Science:

  • Cardiovascular Science
  • Lymphatic Biology
  • Integrative Medicine

Background:

  • Heart disease is a leading cause of global mortality, necessitating novel therapeutic strategies.
  • The lymphatic vasculature is vital for cardiovascular homeostasis, regulating fluid balance and immune cell transport.
  • Impaired cardiac lymphangiogenesis is implicated in various cardiovascular pathologies.

Approach:

  • A scientometric analysis identified lymphangiogenesis as a key research area in cardiovascular disease.
  • This review synthesizes current knowledge on mechanisms of impaired cardiac lymphangiogenesis.
  • Investigated therapeutic strategies to enhance lymphangiogenesis for cardiovascular disease management.

Key Points:

  • Dysfunctional cardiac lymphatics contribute to cardiovascular disease progression.
  • Strategies to promote lymphangiogenesis offer potential therapeutic benefits for heart conditions.
  • Traditional Chinese Medicine (TCM) demonstrates a significant impact on lymphangiogenesis.

Conclusions:

  • Enhancing lymphangiogenesis is a promising avenue for treating cardiovascular diseases.
  • TCM may offer a novel approach to improving cardiovascular health by targeting lymphangiogenesis.
  • Further research is warranted to establish a clinical basis for TCM in cardiovascular therapeutics.

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
5.5K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
431